Abstract
besity and overweight are now considered to be serious health problems, with an increasing prevalence worldwide, 1 such that the World Health Organization (WHO) reported overweight and obesity to be a rising epidemic. 2 Previous studies in Iran showed a high prevalence of obesity. 3 Overall, 11.2% of men and 28.1% of women are obese and 36.6% of Iranian men and 35.9% of women are overweight. 4, 5 O Obesity is an independent risk factor for a number of chronic diseases, including hypertension (HTN), Diabetic Mellitus (DM), cardiovascular disease (CVD) and some cancers. 6 It seems that obesity, DM and HTN are known to increase in both developed and developing populations. 1 Decrease in adiposity is one of the most effective preventive measures in decreasing not only the overall cardiovascular risk but also blood pressure (BP) and increasing DM control. 7 Many studies suggested that lifestyle modification has great potential to reduce obesity and other related cardiovascular risk factors. 8 Some have recently shown effects of lifestyle modification on control of BP and decrease in the incidence of DM in individuals with impaired glucose tolerance. 9 Efforts which focus on changing lifestyle can lead to change people's attitude, behavior and practice in the whole population as well as high risk groups. 10, 11 In this regard, Isfahan Healthy Heart Programme (IHHP), a community-based intervention program, was designed and implemented to prevent CVD and control its related risk factors by promoting healthy lifestyle. IHHP used both the general population and high risk intervention strategies for CVD prevention. 12, 13 In this study, we intended to evaluate the impact of obesity and overweight on DM and HTN control following IHHP interventions.
Methods
IHHP was conducted in three counties, Isfahan and Najaf-Abad as intervention areas and Arak as reference area, all located in central Iran. Arak, placed 375km north-west of Isfahan was selected because of the similarity with the intervention areas regarding socio-economic, demographic and health profile and good cooperation. 13 Started in 2000, the programme was consisted of three phases, the first as baseline survey for situational analysis, the second included implementing interventional activities in the intervention areas (late in [2001] [2002] [2003] [2004] [2005] , and the third as post-intervention survey (2007) to evaluate the programme outcomes. 12, 13 Having resided for more than five years in these cities, not being pregnant for females and being mentally healthy were the criteria for participating in this study. After the baseline survey, a five-year intervention programme was started both in urban and rural areas of Isfahan and Najaf-Abad. Arak was evaluated during this period as the reference area.
During the intervention phase, we took a systematic approach to undertake process, impact and outcome evaluation. 14 Interventional activities were designed in ten projects based on different target groups to address the whole community and specific target populations and subjects in an integrated package. 10 The main themes of interventions included healthy nutrition, tobacco control, physical activity and coping stress. Public and health professionals training, intersectoral collaboration and legislation were among men strategies. Specific educational companion for hypertensive and diabetic patients were implemented. 10 IHHP team conducted the baseline survey on 12514 adults, aged ≥ 19 years in 2000-2001 and carried out the same survey on 9572 adults in 2007 as outcome evaluation. Multistage random sampling was used to select participants in both studies in intervention and reference areas. The sample distribution was consistent with sex and age distribution in the population of three counties. Written informed consents were obtained from all subjects. The methods were in accordance with ethical standards of the Ethical Committee of Isfahan University of Medical Sciences. Full details of the program have been reported elsewhere. 12, 13 Initially, a questionnaire was completed at each subject's home by trained interviewers. It contained demographic information, smoking, nutritional and physical activity habits, medical history, and consumption of relevant medications especially anti-diabetic and antihypertensive agents. Subsequently, participants were invited to certain health centers, where physical examination and blood sampling after 12 to 14 hour fasting were carried out. Subjects were weighed with light clothes and no shoes, and their height was measured and body mass index (BMI) was calculated. 15 Waist circumference (WC) was measured at the midpoint between the iliac crest and the lower margin of the rib to the nearest halfcentimeter. Hip circumference (HC) was measured and waist to hip ratio (WHR) was calculated too. 15 The BP was measured twice with a standardized method, with the subjects in a sitting position, and the average BP was taken into consideration. 12 In addition to fasting plasma glucose (FPG), 2-hour plasma glucose (2hpp) after consumption of 75 gram of glucose was also measured. Serum lipids, including total cholesterol (TC), triglyceride (TG), and HDL-cholesterol (HDL-C) were measured using enzymatic method. LDL cholesterol (LDL-C) was measured using Friedwald formula. 13 All blood sampling procedures were performed in the central laboratory of the Isfahan Cardiovascular Research institute, which is standardized with the Department of Epidemiology, K.U. Leuven, Belgium and Lab Quality External Assessment Services, Helsinki, Finland. Both quality controls showed good correlations.
The subjects of the present study were either hypertensives or diabetics who were selected among all participants of the IHHP study from the baseline and the post-intervention surveys. Controlled HTN was defined as SBP < 140 mmHg or DBP < 90 mmHg and currently taking antihypertensive medications. 16 Controlled DM was defined as FPG < 140 mg/dl and currently taking anti-diabetic treatment. 16 Normal weight was defined as BMI < 25 kg/m 2 and overweight plus obese as BMI ≥ 25 kg/m 2 . 17 Abdominal obesity was defined as WC ≥ 102 cm for men and ≥ 88 cm for women. Gender specific cut-off points of ≥ 0.95 cm and ≥ 0.80 cm for WHR were used for men and women respectively. 15 
Statistical Analysis
Data entry was carried out using EPI info™. All data were analyzed by SPSS (SPSS Inc, Chicago, IL, USA; Version 15). The averages were reported as Mean ± SD and frequencies as percents. For all analyses, statistical significance was assessed at a level of 0.05 (2-tailed Table 2 shows the basic characteristics of controlled diabetic men and women in 2001 and 2007. There was no significant difference in the mean age in both sexes. In the intervention area, WC decreased in women; whereas it increased significantly among men and women in reference area. No significant change was observed in men or women regarding systolic or diastolic BP, TC, TG, HDL-C and LDL-C.
The frequency of HTN control by obesity indices in 2001 and 2007 are presented in table  3 . In women, the frequency of HTN control did not change significantly in normal weight or in those with high BMI, WC or WHR. The pvalue for interaction was significant only for controlled HTN in women with high WC. In men, the frequency of HTN control was only significant among those with high WHR, whereas the p-value for interaction between changes in intervention compared to reference area from 2001 to 2007 was significant in men with normal or high WC or WHR.
The prevalence of controlled DM based on obesity indices in both intervention and reference areas at baseline and after interventions are presented in table 4. In intervention area, the number of women with high BMI who controlled their DM increased significantly from 2001 to 2007 (p = 0.008), however, this figure decreased in men. In reference area obesity indices had no significant association with control of DM. The percentage of diabetic subjects with high WC who controlled their DM decreased non-significantly in intervention area compared to reference area in 2007. However, the p-value for interaction was significant in women. A non-significant increase in controlled DM among men and women with high WHR was observed between intervention and reference area.
Discussion
We observed non-significant changes in DM control in both sexes and HTN control in women following IHHP lifestyle intervention strategies. It can be explained by the nonsignificant changes in obesity in diabetic and hypertensive patients in intervention areas. On the contrary, our results demonstrated that WC decreased significantly in hypertensive women and non-significantly in hypertensive men in intervention area and increased significantly in both sexes in reference areas. In diabetic patients, WC decreased significantly in men in intervention area and increased significantly in women living in reference area. Previous findings from IHHP showed no significant difference regarding BMI and significant decrease of WC between intervention and reference areas at the population level. It is known that weight loss can not only prevent or reverse blood pressure elevations but also have a favorable impact on other obesity-related CVD risk factors such as DM and hyperlipidemia. 7, 18, 19 The interaction between body weight and HTN is very complex and both environmental and genetic factors are involved. 20 Non-pharmacological treatments including lifestyle behaviours have an important role on HTN and DM control. We reported the impact of IHHP on lifestyle behaviours improvement before. 10 Furthermore HTN control reached 15.8% following the implementation of IHHP interventions. 21 Large studies have shown that central obesity has powerful relationship with CVD risk factors. [22] [23] [24] Strong relationship between decreasing abdominal obesity and BP control has been reported specifically in women. In addition to lifestyle behaviors, it could be related to more complex interaction of female hormones with blood pressure. Although lifestyle behaviours have been improved following the implementation of IHHP interventions, 10 however, HTN and DM control was not improved in patients with high BMI or WC who lived in intervention areas.
Conclusion
This study demonstrated that IHHP as a community trial targeting behaviours and CVD risk factors control did not show improving effect on HTN or DM control among obese subjects based on their different obesity indices. Our results suggested that other interventional strategies aiming at decreasing obesity might have an impact on HTN and DM control.
Limitations
As an important limitation, we acknowledge the low rate of controlled hypertensive and diabetic patients in the studied population. This might have affected the difference between two groups based on different obesity indices.
